@article{JGO4407,
author = {Danielle S. Bitterman and David Grew and Ping Gu and Richard F. Cohen and Nicholas J. Sanfilippo and Cynthia G. Leichman and Lawrence P. Leichman and Harvey G. Moore and Heather T. Gold and Kevin L. Du},
title = {Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center},
journal = {Journal of Gastrointestinal Oncology},
volume = {6},
number = {5},
year = {2015},
keywords = {},
abstract = {Objective: To compare clinical and treatment characteristics and outcomes in locally advanced anal cancer, a potentially curable disease, in patients referred from a public or private hospital.
Methods: We retrospectively reviewed 112 anal cancer patients from a public and a private hospital who received definitive chemoradiotherapy at the same cancer center between 2004 and 2013. Tumor stage, radiotherapy delay, radiotherapy duration, and unplanned treatment breaks ≥10 days were compared using t-test and χ2 test. Overall survival (OS), disease free survival (DFS), and colostomy free survival (CFS) were examined using the Kaplan-Meier method and compared with the log-rank test. Cox proportional hazard models for OS and DFS were developed.
Results: The follow-up was 14.9 months (range, 0.7-94.8 months). Public hospital patients presented with significantly higher clinical T stage (P},
issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/4407}
}